FDA Decision On BMY's Drug Postponed, ENTA's PBC Study Fails, MGNX Turns Heads

Today's Daily Dose brings you news about the revised FDA decision date for Bristol Myers' CAR T cell therapy for refractory large B-cell lymphoma; Enanta Pharma's primary biliary cholangitis trial results; MacroGenics' anticipated clinical data read-outs and regulatory event for this year and Trovagene's name change.

from RTT - Biotech https://ift.tt/2xFDuaw
via IFTTT